title: [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
authors: Susanne
authors: S
authors: Alban
authors: Theo
authors: T
authors: Dingermann
authors: Nina
authors: N
authors: Griese
authors: Wolfgang
authors: W
authors: Kämmerer
authors: Manfred
authors: M
authors: Schubert-Zsilavecz
authors: Martin
authors: M
authors: Schulz
authors: Dietmar
authors: D
authors: Trenk
authors: Petra
authors: P
authors: Zagermann-Muncke
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine